Cardiovascular Systems Stock Forecast, Price & News

Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

Is Cardiovascular Systems a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cardiovascular Systems stock.
View analyst ratings for Cardiovascular Systems or view top-rated stocks.

How has Cardiovascular Systems' stock been impacted by Coronavirus (COVID-19)?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CSII shares have decreased by 46.8% and is now trading at $19.33.
View which stocks have been most impacted by COVID-19.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Cardiovascular Systems.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its quarterly earnings data on Monday, November, 8th. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.12. The medical device company had revenue of $58.40 million for the quarter, compared to analysts' expectations of $63.72 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 7.40% and a negative net margin of 7.77%. The business's quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the company posted ($0.05) earnings per share.
View Cardiovascular Systems' earnings history.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its FY 2022 earnings guidance on Tuesday, November, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $265 million-$285 million, compared to the consensus revenue estimate of $295.53 million.

What price target have analysts set for CSII?

7 Wall Street analysts have issued 12-month price targets for Cardiovascular Systems' shares. Their forecasts range from $40.00 to $49.00. On average, they anticipate Cardiovascular Systems' stock price to reach $43.40 in the next year. This suggests a possible upside of 124.5% from the stock's current price.
View analysts' price targets for Cardiovascular Systems or view top-rated stocks among Wall Street analysts.

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:

• Scott R. Ward, Chairman, President & Chief Executive Officer
• Rhonda J. Robb, Chief Operating Officer
• Jeffrey S. Points, Chief Financial Officer
• Ryan D. Egeland, Chief Medical Officer
• Sandra M. Sedo, Chief Compliance Officer

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

12 employees have rated Cardiovascular Systems CEO Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among Cardiovascular Systems' employees.

Who are some of Cardiovascular Systems' key competitors?

Some companies that are related to Cardiovascular Systems include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), DexCom (DXCM), IDEXX Laboratories (IDXX), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Hologic (HOLX) and Masimo (MASI).
View all of CSII's competitors.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.50%), Janus Henderson Group PLC (3.76%), Renaissance Technologies LLC (2.57%), New York State Common Retirement Fund (1.89%), Geode Capital Management LLC (1.85%) and Invesco Ltd. (1.62%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems.

Which major investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, BlackRock Inc., Janus Henderson Group PLC, Macquarie Group Ltd., Eagle Asset Management Inc., Granahan Investment Management Inc. MA, Two Sigma Investments LP, and Perkins Capital Management Inc..
View insider buying and selling activity for Cardiovascular Systems or view top insider-selling stocks.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Invesco Ltd., Assenagon Asset Management S.A., Goldman Sachs Group Inc., AlphaCrest Capital Management LLC, Millennium Management LLC, Summit Global Investments, and Exchange Traded Concepts LLC. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, and Scott R Ward.
View insider buying and selling activity for Cardiovascular Systems or or view top insider-buying stocks.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $19.33.

How much money does Cardiovascular Systems make?

Cardiovascular Systems has a market capitalization of $783.85 million and generates $258.97 million in revenue each year. The medical device company earns $-13.42 million in net income (profit) each year or ($0.51) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

Cardiovascular Systems employs 779 workers across the globe.

When was Cardiovascular Systems founded?

Cardiovascular Systems was founded in 1989.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

Where are Cardiovascular Systems' headquarters?

Cardiovascular Systems is headquartered at 1225 OLD HWY 8 NW, ST. PAUL MN, 55112.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at (651) 259-1600, via email at [email protected], or via fax at 612-677-3355.